Emax model [REMOVE_ME]f(d,theta)=E0+Emaxd/(ED50+d).[REMOVEME2][REMOVE_ME]f(d,θ)=E0+EmaxED50+ddf(d,theta)=E0+Emaxd/(ED50+d).[REMOVEME2]
Sigmoid Emax Model [REMOVE_ME]f(d,theta)=E0+Emaxdh/(ED50h+dh).[REMOVEME2][REMOVE_ME]f(d,θ)=E0+EmaxED50h+dhdhf(d,theta)=E0+Emaxdh/(ED50h+dh).[REMOVEME2]
Exponential Model [REMOVE_ME]f(d,theta)=E0+E1(exp(d/delta)−1).[REMOVEME2][REMOVE_ME]f(d,θ)=E0+E1(exp(d/δ)−1)f(d,theta)=E0+E1(exp(d/delta)−1).[REMOVEME2]
Beta model [REMOVE_ME]f(d,theta)=E0+EmaxB(delta1,delta2)(d/scal)delta1(1−d/scal)delta2[REMOVEME2][REMOVE_ME]f(d,θ)=E0+EmaxB(δ1,δ2)(d/scal)δ1(1−d/scal)δ2f(d,theta)=E0+EmaxB(delta1,delta2)(d/scal)delta1(1−d/scal)delta2[REMOVEME2]
[REMOVE_ME]f(d,theta)=E0+EmaxB(delta1,delta2)(d/scal)delta1(1−d/scal)delta2[REMOVEME2] here [REMOVE_ME]B(δ1,δ2)=(δ1+δ2)δ1+δ2/(δ1δ1B(delta1,delta2)=(delta1+delta2)(delta1+delta2)/(delta1delta1delta2delta2).[REMOVEME2][REMOVE_ME]δ2δ2)B(delta1,delta2)=(delta1+delta2)(delta1+delta2)/(delta1delta1delta2delta2).[REMOVEME2] and scal is a fixed dose scaling parameter.
Linear Model [REMOVE_ME]f(d,theta)=E0+deltad.[REMOVEME2][REMOVE_ME]f(d,θ)=E0+δdf(d,theta)=E0+deltad.[REMOVEME2]
Linear in log Model [REMOVE_ME]f(d,theta)=E0+deltalog(d+off),[REMOVEME2][REMOVE_ME]f(d,θ)=E0+δlog(d+off)f(d,theta)=E0+deltalog(d+off),[REMOVEME2]
here off is a fixed offset parameter.
Logistic Model [REMOVE_ME]f(d,θ)=E0+Emax/{1+exp[(ED50−d)/δ]}f(d,theta)=E0+Emax/(1+exp((ED50−d)/delta)).[REMOVEME2]
Quadratic Model [REMOVE_ME]f(d,theta)=E0+beta1d+beta2d2.[REMOVEME2][REMOVE_ME]f(d,θ)=E0+β1d+β2d2f(d,theta)=E0+beta1d+beta2d2.[REMOVEME2] The standardized model equation for the quadratic model is d+deltad2, with delta=beta2/beta1.
Linear Interpolation model
The linInt model provides linear interpolation at the values defined by the nodes vector. In virtually all situations the nodes vector is equal to the doses used in the analysis. For example the Mods and the fitMod function automatically use the doses that are used in the context of the function call as nodes. The guesstimates specified in the Mods function need to be the treatment effects at the active doses standardized to the interval [0,1] (see the examples in the Mods function).
e0: For most models placebo effect. For logistic model left-asymptote parameter, corresponding to a basal effect level (not the placebo effect)
eMax: Beta Model: Maximum effect within dose-range
Emax, sigmoid Emax, logistic Model: Asymptotic maximum effect
ed50: Dose giving half of the asymptotic maximum effect
...: Just included for convenience in the gradient functions, so that for example quadratic(dose, e0=0, b1=1, b2=3) will not throw an error (although the gradient of the quadratic model is independent of e0, b1 and b2).
h: Hill parameter, determining the steepness of the model at the ED50
e1: Slope parameter for exponential model
delta: Exponential model: Parameter, controlling the convexity of the model.
Linear and linlog model: Slope parameter
Logistic model: Parameter controlling determining the steepness of the curve
b1: first parameter of quadratic model
b2: second parameter of quadratic model (controls, whether model is convex or concave)
delta1: delta1 parameter for beta model
delta2: delta2 parameter for beta model
scal: Scale parameter (treated as a fixed value, not estimated)
off: Offset value to avoid problems with dose=0 (treated as a fixed value, not estimated)
resp: Response values at the nodes for the linInt model
nodes: Interpolation nodes for the linear interpolation for the linInt model (treated as a fixed value, not estimated)
Returns
Response value for model functions or matrix containing the gradient evaluations.
The standardized model equation for the quadratic model is d+deltad2, with delta=beta2/beta1.
Linear Interpolation model
The linInt model provides linear interpolation at the values defined by the nodes vector. In virtually all situations the nodes vector is equal to the doses used in the analysis. For example the Mods and the fitMod function automatically use the doses that are used in the context of the function call as nodes. The guesstimates specified in the Mods function need to be the treatment effects at the active doses standardized to the interval [0,1] (see the examples in the Mods function).
Details
The Emax model is used to represent monotone, concave dose-response shapes. To distinguish it from the more general sigmoid emax model it is sometimes also called hyperbolic emax model.
The sigmoid Emax model is an extension of the (hyperbolic) Emax model by introducing an additional parameter h, that determines the steepness of the curve at the ed50 value. The sigmoid Emax model describes monotonic, sigmoid dose-response relationships. In the toxicology literature this model is also called four-parameter log-logistic (4pLL) model.
The quadratic model is intended to capture a possible non-monotonic dose-response relationship.
The exponential model is intended to capture a possible sub-linear or a convex dose-response relationship.
The beta model is intended to capture non-monotone dose-response relationships and is more flexible than the quadratic model. The kernel of the beta model function consists of the kernel of the density function of a beta distribution on the interval [0,scal]. The parameter scal is not estimated but needs to be set to a value larger than the maximum dose. It can be set in most functions (fitMod , Mods ) via the addArgs argument, when omitted a value of 1.2*(maximum dose)
is used as default, where the maximum dose is inferred from other input to the respective function.
The linear in log-dose model is intended to capture concave shapes. The parameter off is not estimated in the code but set to a pre-specified value. It can be set in most functions (fitMod , Mods ) via the addArgs argument, when omitted a value of 0.01*(maximum dose) is used as default, where the maximum dose is inferred from other input to the respective function.
The logistic model is intended to capture general monotone, sigmoid dose-response relationships. The logistic model and the sigmoid Emax model are closely related: The sigmoid Emax model is a logistic model in log(dose).
The linInt model provids linear interpolation of the means at the doses. This can be used as a "nonparametric" estimate of the dose-response curve, but is probably most interesting for specifying a "nonparametric" truth during planning and assess how well parametric models work under a nonparametric truth. For the function Mods and fitMod the interpolation nodes are selected equal to the dose-levels specified.
Examples
## some quadratic example shapesquadModList <- Mods(quadratic = c(-0.5,-0.75,-0.85,-1), doses = c(0,1))plotMods(quadModList)## some emax example shapesemaxModList <- Mods(emax = c(0.02,0.1,0.5,1), doses = c(0,1))plotMods(emaxModList)## example for gradientemaxGrad(dose =(0:4)/4, eMax =1, ed50 =0.5)## some sigmoid emax example shapessigEmaxModList <- Mods(sigEmax = rbind(c(0.05,1), c(0.15,3), c(0.4,8), c(0.7,8)), doses = c(0,1))plotMods(sigEmaxModList)sigEmaxGrad(dose =(0:4)/4, eMax =1, ed50 =0.5, h =8)## some exponential example shapesexpoModList <- Mods(exponential = c(0.1,0.25,0.5,2), doses=c(0,1))plotMods(expoModList)exponentialGrad(dose =(0:4)/4, e1 =1, delta =2)## some beta model example shapesbetaModList <- Mods(betaMod = rbind(c(1,1), c(1.5,0.75), c(0.8,2.5), c(0.4,0.9)), doses=c(0,1), addArgs=list(scal =1.2))plotMods(betaModList)betaModGrad(dose =(0:4)/4, eMax =1, delta1 =1, delta2 =1, scal =5)## some logistic model example shapeslogistModList <- Mods(logistic = rbind(c(0.5,0.05), c(0.5,0.15), c(0.2,0.05), c(0.2,0.15)), doses=c(0,1))plotMods(logistModList)logisticGrad(dose =(0:4)/4, eMax =1, ed50 =0.5, delta =0.05)## some linInt shapesgenModList <- Mods(linInt = rbind(c(0.5,1,1), c(0,1,1), c(0,0,1)), doses=c(0,0.5,1,1.5))plotMods(genModList)linIntGrad(dose =(0:4)/4, resp=c(0,0.5,1,1,1), nodes=(0:4)/4)
References
MacDougall, J. (2006). Analysis of dose-response studies - Emax model,in N. Ting (ed.), Dose Finding in Drug Development, Springer, New York, pp. 127--145
Pinheiro, J. C., Bretz, F. and Branson, M. (2006). Analysis of dose-response studies - modeling approaches, in N. Ting (ed.). Dose Finding in Drug Development, Springer, New York, pp. 146--171